Vor Biopharma VOR Comprehensive Income (Loss), Net of Tax, Attributable to Parent
Comprehensive Income (Loss), Net of Tax, Attributable to Parent at other companies
Other financials
Where this comes from
Reported directly by Vor Biopharma in its filing.
Tagged under the XBRL concept us-gaap:ComprehensiveIncomeNetOfTax.
The official record: Vor Biopharma’s 10-Q, filed May 13, 2026, on SEC EDGAR. View the filing →
Ask your AI about Vor Biopharma's comprehensive income (loss), net of tax, attributable to parent.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Vor Biopharma's comprehensive income (loss), net of tax, attributable to parent?
- Vor Biopharma (VOR) reported comprehensive income (loss), net of tax, attributable to parent of -$220.33M in Q1 2026.
- How has Vor Biopharma's comprehensive income (loss), net of tax, attributable to parent changed year-over-year?
- Vor Biopharma's comprehensive income (loss), net of tax, attributable to parent decreased by 578.3% year-over-year, from -$32.49M to -$220.33M.
- What is the long-term trend for Vor Biopharma's comprehensive income (loss), net of tax, attributable to parent?
- Over 3 years (2021 to 2024), Vor Biopharma's comprehensive income (loss), net of tax, attributable to parent has grown at a 18.5% compound annual growth rate (CAGR), from -$70.13M to -$116.82M.
- What does comprehensive income (loss), net of tax, attributable to parent mean?
- This represents the total change in equity from non-owner sources, encompassing both net income and other comprehensive income items such as unrealized gains or losses on securities. It provides a more holistic view of the company's financial performance by including items that bypass the traditional income statement. Investors use this to assess the total impact of all financial activities on the company's net worth.